InvestLog
RARE logo

RARE

Ultragenyx Pharmaceutical Inc.NASDAQHealthcare
$22.45+1.87%ClosedMarket Cap: $2.17B

As of 2026-04-06

Insider Statistics (Q2 2026)

Purchases

0

Sales

1

Buy/Sell Ratio

0.00

Total Bought

$0.00

Total Sold

$1.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Thu Apr 02Horn Howardofficer: Chief Financial OfficerSell4,683$20.9780,351
Tue Mar 10Parschauer Karah Herdmanofficer: EVP and Chief Legal OfficerSell3,508$22.6766,820
Tue Mar 10Parschauer Karah Herdmanofficer: EVP and Chief Legal OfficerSell6,018$21.4070,328
Tue Mar 03Pinion John Richardofficer: See RemarksSell10,029$22.80110,026
Tue Mar 03Harris Erikofficer: EVP & Chief Commercial OfficerSell11,643$0.0099,498
Tue Mar 03Harris Erikofficer: EVP & Chief Commercial OfficerSell10,539$22.8089,515
Tue Mar 03KAKKIS EMIL Ddirector, officer: President & CEOSell71,177$0.00712,908
Tue Mar 03KAKKIS EMIL Ddirector, officer: President & CEOSell54,404$22.80658,994
Tue Mar 03Parschauer Karah Herdmanofficer: EVP and Chief Legal OfficerSell11,137$0.0084,408
Tue Mar 03Parschauer Karah Herdmanofficer: EVP and Chief Legal OfficerSell8,135$22.8076,346
Tue Mar 03Pinion John Richardofficer: See RemarksSell11,137$0.00119,565